| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $174.4M | +64.0% |
| Cost of Revenue | $90.2M | +61.3% |
| Gross Profit | $84.3M | +67.0% |
| R&D Expense | $62.4M | +140.5% |
| SG&A Expense | $156.6M | +78.9% |
| Operating Income | -$175.2M | -128.8% |
| Pre-tax Income | -$138.3M | -86.4% |
| Income Tax | $573K | +26.8% |
| Net Income | -$138.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $166.7M | +222.5% |
| Accounts Receivable | $33.6M | +70.9% |
| Inventory | $40.7M | +98.4% |
| Current Assets | $375.9M | +137.6% |
| Total Assets | $612.3M | +89.5% |
| Current Liabilities | $65.9M | -39.7% |
| Long-term Debt | $299K | -99.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$143.5M | -231.4% |
| Capital Expenditures | $8.4M | +195.1% |
| Investing Cash Flow | $363.2M | +1694.6% |
| Financing Cash Flow | -$102.6M | -1407.1% |
| Free Cash Flow | -$151.8M | -229.2% |
| -86.0% |
| EPS (Basic) | -$0.52 | +44.7% |
| EPS (Diluted) | -$0.52 | +44.7% |
| Total Liabilities |
| $140.6M |
| -12.0% |
| Stockholders' Equity | $471.7M | +418.6% |